PAR
Click for more information
5.10% 25.8¢ paradigm biopharmaceuticals limited..

Competition???, page-44

  1. Chel6888
    209 Posts.
    lightbulb Created with Sketch. 28
    clock Created with Sketch.
    10/10/22
    07:26
    Post #: 64110424
    just found a comment below the YouTube video regarding sprifermin. Here is the screenshot
    https://hotcopper.com.au/data/attachments/4739/4739784-c8ea1490922507815a8c90421edf3b66.jpg
    Conclusion for phase 2 trial of sprifermin
    https://hotcopper.com.au/data/attachments/4739/4739786-5fd14efb06cccbc01ffb71d44a4fe5fc.jpg
    here is YouTube link
    PAR Price at posting: $1.68 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TG1 TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
right-arrow Created with Sketch.
LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
WCN White Cliff wraps up Canadian fieldwork programs – 'visually confirming' a slew of minerals
right-arrow Created with Sketch.
MTL Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
right-arrow Created with Sketch.
POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
MAG Magmatic defines 6km copper trend with grades of up to 6.5% at NSW prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.8¢ 		Change
0.013(5.10%) 		Mkt cap ! $87.44M
Open High Low Value Volume
24.5¢ 26.0¢ 24.5¢ $14.89K 59.10K

Buyers (Bids)

No. Vol. Price($)
2 2612 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 29801 4
View Market Depth
Last trade - 11.49am 01/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.